Diet and Microbiome Longitudinal Monitoring With Food Intervention
1 other identifier
interventional
65
1 country
1
Brief Summary
The main goal of this project is to identify the microbiome components change in abundance in response to food ingested including provided foods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2021
CompletedFirst Submitted
Initial submission to the registry
February 8, 2021
CompletedFirst Posted
Study publicly available on registry
February 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 28, 2030
October 21, 2024
October 1, 2024
9.1 years
February 8, 2021
October 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Microbiota variation
Ecological statistics will be used to analyze the longitudinal microbiome composition modification
Up to 2 weeks
Study Arms (1)
Food provided
OTHERFood provided from a commercial meal service provider for a week
Interventions
Meals from a commercial meal service provider provide for a week to participant
Eligibility Criteria
You may qualify if:
- willing to sign consent and have samples collected,
- able to read and speak English,
- participants must be willing to use an electronic food diary and consume study provided foods,
- only individuals able to provide a US address will be included.
You may not qualify if:
- Subjects not able to sign consent on their own accord (ie requiring a Legally Authorized Representative \[LAR\]),
- Current parenteral nutrition,
- Received cancer treatment within past 6 months prior to signing consent,
- Taken antibiotic treatment within the past 1 month prior to signing consent,
- Received oral x-ray contrast within the past 1 month prior to signing consent,
- Received any type of gastrointestinal bowel preparation in the past 1 month prior to signing consent,
- History of organ transplant,
- Shellfish allergy,
- Insect allergy,
- Cacti allergy,
- Carmine allergy,
- Dragon fruit (pitaya) allergy,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Nebraska - Lincoln
Lincoln, Nebraska, 68588, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Jacques Izard, PhD
Univeristy of Nebraska-Lincoln
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2021
First Posted
February 17, 2021
Study Start
February 2, 2021
Primary Completion (Estimated)
February 28, 2030
Study Completion (Estimated)
February 28, 2030
Last Updated
October 21, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share